Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Maximizing credit card point value can lead to incredible benefits. Discover effective strategies to boost your rewards potential.
25,565 articlesA biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...
Tesla’s 2026 year foundational growth centers on ramping four key initiatives that lay the groundwork for the next wa...
The Milan-based Italian acquirer, known for reviving fading apps, has filed for a U.S. IPO, revealing sharp revenue g...
SpaceX begins trading on Nasdaq, positioning Elon Musk for trillionaire status as investors bet on a bold, multi-plan...
Kraft Heinz is rolling out TSA-approved ranch travel kits to ride the World Cup ranch craze. The move targets travele...
Ford bets on human experience to guide AI, tapping 350 veteran engineers to steer its technology push as recalls and ...
Palantir surging in July shines a contrast with Google’s cloud-driven growth. Both giants report strong quarters, but...
Palantir surges on AI hype while Salesforce shows real earnings growth and cash flow. This piece explains why investo...
A little-known robotics ETF is trading at a discount, offering broad exposure as robotics ETFs will dominate in the c...
Looking for a few durable holdings to anchor a decades-long portfolio? Here are three monster stocks hold next—giants...
Root Insurance posted its first underwriting profit in 2025, delivering $40.3 million in net income on $1.5 billion i...
Advanced Micro Devices stock dropped sharply last month as tech valuations cooled. This guide breaks down the drivers...